Kinematics Analysis of SIGMA® Partial Knee System

NCT ID: NCT02949336

Last Updated: 2019-01-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

18 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-12-19

Study Completion Date

2017-12-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The proposed study is a prospective collection of health related personal data (observational study). A total of approximately 10 subjects with traditional medial SIGMA® High Performance Partial Knee System and 10 ACL deficient subjects with medial SIGMA® High Performance Partial Knee System are analyzed during sitting onto a chair and getting up, deep knee bend, stance and swing phase of level walking, downhill walking (ramp descent) and stair descent at least 12 months post-operatively, in terms of 3D fluoroscopic assessed tibio-femoral motion as well as simultaneous skin marker assessed whole leg motion and ground reaction forces. All the video-fluoroscopic testing is performed at the Institute for Biomechanics at the ETH Zurich. The UKA subjects are recruited based on the inclusion and exclusion criteria.

The primary objective is to quantify and describe the three-dimensional kinematics for patients with a traditional medial SIGMA® High Performance Partial Knee System (functional ACL and tibial posterior slope matching the native bone) during these daily activities.

The secondary objective is to evaluate patients with the same medial UKA implant (SIGMA® High Performance Partial Knee System) in an ACL deficient knee, where the UKA was implanted at a 50% reduced tibial posterior slope relative to the native knee.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The knee arthroplasty for each patient was implanted more than one year ago as per inclusion criteria of this study with the sole purpose of standard clinical practice of the recruiting surgeons.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Unicompartmental Knee Arthroplasty

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1: Traditional UKA

Patients with a traditional Medial Unicompartmental Knee Arthroplasty, SIGMA® High Performance Partial Knee System (functional ACL and tibial posterior slope matching the native bone) will undergo observational use of fluoroscopy to analyze joint kinematics

Observational use of fluoroscopy

Intervention Type RADIATION

Minimal radiation exposure (0.17 mSv) for observational purpose

Group 2: ACL deficient UKA

Patients with the same medial UKA implant (SIGMA® High Performance Partial Knee System) in an ACL deficient knee, where the UKA was implanted at a 50% reduced tibial posterior slope relative to the native knee will undergo observational use of fluoroscopy to analyze joint kinematics.

Observational use of fluoroscopy

Intervention Type RADIATION

Minimal radiation exposure (0.17 mSv) for observational purpose

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Observational use of fluoroscopy

Minimal radiation exposure (0.17 mSv) for observational purpose

Intervention Type RADIATION

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* medial SIGMA® High Performance Partial Knee System due to medial OA
* Intact/functional ACL
* BMI ≤ 32
* good clinical outcome, KOOS \>70
* no or very low pain VAS \< 2
* Follow-up at least one year post-op
* Standardized general health survey score (SF-12) within the normal range for people in their age group
* Age ≥ 18 years


* medial SIGMA® High Performance Partial Knee System due to medial OA
* Deficient / non-functional ACL
* Central to posterior wear of medial tibial plateau (pre-op MRI)
* 50% reduced tibial posterior slope after UKA (post-op radiograph)
* BMI ≤ 32
* good clinical outcome, KOOS \>70
* no or very low pain VAS \< 2
* Follow-up at least one year post-op
* Standardized general health survey score (SF-12) within the normal range for people in their age group
* Age ≥ 18 years

Exclusion Criteria

* Actual significant problem on lower extremities
* Misaligned UKA
* Deficient / non-functional ACL (Lachman Test)
* Any other arthroplasty at the lower extremities
* Patient incapable to understand and sign informed consent
* Incapable of performing the motion tasks
* Pregnancy


* Actual significant problem on lower extremities
* Misaligned UKA / non-reduced posterior tibial slope (post-op radiograph)
* Intact / functional ACL
* Any other arthroplasty at the lower extremities
* Patient incapable to understand and sign informed consent
* Incapable of performing the motion tasks
* Pregnancy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Schulthess Klinik

OTHER

Sponsor Role collaborator

DePuy Synthes

INDUSTRY

Sponsor Role collaborator

Gelenkzentrum Zurich

UNKNOWN

Sponsor Role collaborator

Stephen Ferguson

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Stephen Ferguson

Prof. Dr.

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stephen Ferguson, Prof. Dr.

Role: STUDY_DIRECTOR

Institute for Biomechanics, ETH Zurich

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institute for Biomechanics, ETH Zurich

Zurich, Canton of Zurich, Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UKA V 2.4 02.09.2016

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.